Home/ Supplements/ Lysine/ L-Lysine 1000 mg

L-Lysine 1000 mg

product on market Tablet or Pill The Vitamin Shoppe Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for L-Lysine 1000 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
Amino acid/Protein
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

1000 mg
Market median: 500.0mg (159 products)

Other Ingredients

Microcrystalline Cellulose Hydroxypropyl Cellulose Stearic Acid Croscarmellose Sodium Hydroxypropyl Methylcellulose Magnesium Stearate Silica Polyethylene Glycol
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take one (1) tablet daily, preferably between meals.

Warnings & Precautions

Warning: Consult your healthcare provider prior to use if you are pregnant, nursing, taking any medications, have any medical conditions or have any difficulty swallowing.

Keep out of reach of children.

Tamper evident Do not use if outer seal is broken or missing.

Formulation Notes

Essential amino acid

Collagen and elastin production Immune support

Gluten-free Dairy-free Soy-free Nut-free

Does not contain: Gluten, sugar, salt, artificial colors or flavors.

Additional Information

Specialty

Quality Promise Tested & Trusted

Store in a cool, dry place.

Metadata

Product Details

UPC / SKU7 66536 01940 3
DSLD Entry Date2020-05-22
Product TypeAmino acid/Protein
FormTablet or Pill
DSLD ID221603
Data Updated2026-04-11
Research

Research Evidence

3
Research Sources
74
Avg Quality
3
Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Lysine →
Compare

Similar Products

View all Lysine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.